Routine succession planning for a non-CEO/CFO role with an internal successor already in place. No trading implications; monitor the 10-K filing in February 2027 for any related financial disclosures.
Price Chart
Executive Summary
Travere Therapeutics announced the planned retirement of CAO Sandra Calvin after the filing of the 2026 10-K (expected February 2027), with VP Controller John Torell set to succeed her. The transition is orderly with an internal replacement already named, making this a routine personnel event with no material financial impact.
Key Facts
- CAO Sandra Calvin intends to retire following the filing of the 2026 annual report (expected February 2027).
- John Torell, CFA, CPA, currently VP Controller, is expected to succeed her as CAO and PAO.
- Torell joined Travere in 2021 and has overseen accounting operations, financial reporting, SEC reporting, and internal controls.
- The Board is expected to appoint Torell in advance of the Retirement Date to ensure an orderly transition.
Financial Impact
No financial impact from this executive transition.
Risk Factors
- Potential disruption if the transition timeline shifts or if Torell declines the appointment, though the filing indicates a clear plan.
- No other risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001438533-26-000054 |
| Document: 0001438533-26-000054-index-headers.html | 0001438533-26-000054 |
| Document: 0001438533-26-000054-index.html | 0001438533-26-000054 |
| Document: 0001438533-26-000054.txt | 0001438533-26-000054 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 8-K | $56.59 $61.32 | ▲ +8.36% | ▲ +5.93% | $56.93 (+0.60%) |
Jun 16, 2026 15w ago | Insider Cluster | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 16, 2026 15w ago | 8-K | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 12, 2026 16w ago | 144 | $52.04 $56.59 | ▲ +8.74% | ▲ +6.96% | $56.93 (+9.40%) |
Jun 2, 2026 17w ago | 8-K | $42.96 $56.34 | ▲ +31.15% | ▲ +32.71% | $56.93 (+32.52%) |
May 15, 2026 20w ago | 144 | $42.59 $53.80 | ▲ +26.32% | ▲ +24.20% | $56.93 (+33.67%) |
May 5, 2026 21w ago | 144 | $44.76 $45.20 | ▲ +0.98% | ▼ −1.80% | $56.93 (+27.19%) |
May 4, 2026 21w ago | 144 | $44.80 $42.96 | ▼ −4.11% | ▼ −9.06% | $56.93 (+27.08%) |
May 1, 2026 22w ago | Insider Cluster | $44.12 $45.04 | ▼ −2.09% | ▲ +3.20% | $56.93 (−29.03%) |
Apr 15, 2026 24w ago | 144 | $40.95 $42.84 | ▲ +4.62% | ▼ −1.43% | $56.93 (+39.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access